The celiac disease vaccine enters phase 3
Phase two of the tests, which started in August, showed incredible results. The vaccine for celiac disease goes into the carriage for commercialization.
Phase two of the tests, which started in August, showed incredible results. The vaccine for celiac disease goes into the carriage for commercialization.
The treatment developed by an Australian biotech company aims to reprogram the immune system to make it tolerant to gluten.
Alberto Robiati and Gianluca Riccio guide readers through scenarios of the future: the opportunities, risks and possibilities we have to create a possible tomorrow.
News about the world of tomorrow.
We give news about the future of technology, science and society: if there is one thing that is about to arrive, it has already arrived here.
Category
Language editions
© 2024 Near future - This work is distributed under license Creative Commons Attribution 4.0 International.